Intrinsic molecular subtyping enables fine-tuned prognosis and prediction of tumor behavior in patients with advanced breast cancer

Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s (VHIO) Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics…

Be the first to comment

Leave a Reply

Your email address will not be published.


*